Thor Medical ASA

OB:TRMED Stock Report

Market Cap: NOK 617.7m

Thor Medical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Jasper Kurth

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure1.5yrs

Recent management updates

Recent updates

CEO

Jasper Kurth (39 yo)

less than a year

Tenure

Mr. Jasper Kurth is Chief Executive Officer of Thor Medical ASA from August 1, 2024. Mr. Jasper Kurth joined Thor Medical from several positions at Bayer Pharmaceuticals, most recently as General Manager R...

Leadership Team

NamePositionTenureCompensationOwnership
Jasper Kurth
Chief Executive Officerless than a yearno datano data
Brede Ellingsæter
Chief Financial Officer1.4yrsno datano data
Sindre Hassfjell
Chief Technology Officer1.5yrsno data0.034%
NOK 210.4k
Sven Røst
Vice President of Communicationsno datano datano data
Alf Bjørseth
Senior VP of Business Development & Strategic Advisorless than a yearno data0.19%
NOK 1.2m

0.9yrs

Average Tenure

Experienced Management: TRMED's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Roy Larsen
Member of Technical Advisory Boardno datano data0.85%
NOK 5.3m
Mimi Berdal
Independent Director1.5yrsno datano data
John Andersen
Director1.5yrsNOK 300.00kno data
Ludvik Sandnes
Independent Chairman of the Board1.5yrsno data0.10%
NOK 631.2k
Brit Farstad
Member of Technical Advisory Boardno datano datano data

1.5yrs

Average Tenure

65yo

Average Age

Experienced Board: TRMED's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 06:21
End of Day Share Price 2024/12/30 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Thor Medical ASA is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution